3 points of clarity to aid in treatment decisions
Explain to your patients their Recurrence Score result
Download physician-to-patient explanatory brochures
Landmark TAILORx Results
The long-awaited results of the Trial Assigning IndividuaLized Options for Treatment (TAILORx) definitively identified the vast majority of women with early stage breast cancer who will receive no benefit from chemotherapy, and the minority for whom chemotherapy can be life-saving.